Volume 20 No 9 (2022)
 Download PDF
In silico Pharmacokinetics and Docking Analysis of Active Biomolecules from 5-Amino-Salicylic Acid against Cyclin Dependent Kinase II
Mr. Sagar Ashok Jadhav, Dr. Dhanya B. Sen, Dr. Ashim Kumar Sen, Mr. Ashish P. Shah
Abstract
Docking is a crucial tool in molecular design and development because it predicts the supported path of one particle to the next when they are bonded together to form a stable and flighty complex. As a result, information about the supported bearing can be used to estimate the strength of the connection and the binding attraction between a ligand and a target molecule. Aim: A number of possible compounds derived from the specified scheme were examined for their binding modes, interactions, and specific binding sites against Cyclin Dependent Kinase II as part of this study. Methods: In silico molecular docking of probable compounds acquired from designed scheme was executed utilizing Chemdraw, Swiss ADME, Molsoft, Molinspiration, Pymol and Autodock Vina software. Results: The current investigation was done to comprehend the drug-likeness character of novel derivatives and their binding affinity with 6GUH. Conclusion: The assessment offers confirmation to considered significant ligands auxiliaries potential Cyclin Dependent Kinase II inhibitor and further in vitro and in vivo assessments may demonstrate its remedial potential.
Keywords
Docking, Autodock Vina, 5-ASA, Anticancer activity, PDB, Pymol, Cyclin Dependent Kinase II
Copyright
Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.